Rare mutations account for 10–15% of all EGFR mutations in NSCLC and include G719A or G719S, Del18, E709K, exon 19 insertions, S768I, L861Q and exon 20 insertions (Ins20). This evidence concerns the gene EGFR and non-small cell lung carcinoma.